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Recurrent puncture of dialysis grafts can cause erosion and ulcer formation in the skin over the prosthetic material.
Contamination of the wound can lead to infection of the graft, and the necessity to remove it. We describe four cases where
agressive treatment with debridement, intravenous antibiotics and negative pressure therapy allowed prosthesis salvage
without discontinuation of hemodialysis.
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Introduction
Several complications associated with expanded poly-
tetrafluoroethylene (ePTFE) graft placement for hemo-
dialysis vascular access has been described. The
leading cause of patient morbidity as well as access
failure is infection.1,2 Recurrent puncture of dialysis
grafts may cause erosion and ulcer formation in the
skin over the prosthetic material.2 Contamination of
the wound can lead to infection of the graft and the
necessity to remove it surgically.3 A vacuum-assisted
closure device (VAC) is used for the management of
complicated wounds; it is associated with accelerated
development of granulation tissue, earlier reepithelia-
lization of wounds and decreased wound bacterial
counts.4,5
To allow salvage of ePTFE grafts we used a vacuum
dressing combined with intravenous antibiotics after
debridement of the wound in four cases.
Short Report
Four cases of wound dehiscence over ePTFE grafts for
hemodialysis access presented between September
and November 2002. There were three men and one
woman, and the median age was 66.2 years old.
Treatment consisted of debridement of the wound and
application of a vacuum dressing, combined with
intravenous antibiotics, after blood cultures and a
swab of the wound were taken for microbiological
examination. VAC consisted of placing a dressing
sponge made of open-cell polyurethane ether foam
onto the wound. Embedded in this sponge was a
noncollapsible, sideported evacuation tube connected
to an adjustable vacuum pump. A plastic adhesive
drape was placed over the sponge to obtain an airtight
seal. The vacuum pressure was adjustable up to
2125 mmHg and was used intermittently. Dressings
were removed every 3–4 days. The pump, we used
was a portable small pump designed for ambulatory
treatment (KCI, San Antonio, TX, USA).
Patients 1 and 2 developed wound dehiscence over
the graft after repeated skin puncture (Fig. 1). Patient 3
had a wound dehiscence following surgery after a
small infected haematoma was evacuated over the
alloplastic material. Patient 4 developed a voluminous
haematoma at the anterior aspect of the elbow after
puncture. Blood cultures taken at the time of admis-
sion were sterile in all cases. Both haematomas were
infected with Staphylococcus aureus and Staphylococcus
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epidermidis, respectively. Antibiotics were stopped if
the culture were sterile and maintained for a total of 15
days if pathology was identified. Retraction of the
wound over the ePTFE graft was obtained in patients
1–3 with development of granulation tissue on two
thirds of the graft’s circumference. Coverage of the
alloplastic material was obtained by a local skin flap
done under local anaesthesia (Fig. 2). For patient 4,
coverage was obtained after direct closure under
general anaesthesia. Wounds have been stable from 7
to 9 months. During all the treatment hemodialysis
was continued using the same vascular access.
Subatmospheric suction did not impair AVF outflow.
Discussion
Infection accounts for about 20% of all vascular access
complications.2 Native primary AVF have the lowest
rate of infectious complications. Permanent dual-
lumen venous catheters and ePTFE grafts have a
much higher complication rate. Poor healing after
Fig. 1. Close view of the wound dehiscence over prosthetic material.
Fig. 2. Result after local skin flap.
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graft placement can cause erosion of the overlying skin
with exposure and contamination of the graft. Hae-
matomas can occasionally form around anastomosis
sites and as well as seromas can act as infectious
niduses developing into perigraft abscesses. Most of
all, repeated needle puncture is the most common
cause of infection.2 These mechanical injuries might
result in ulcer formation overlying the access, which
can become secondarily infected. If left untreated,
infection can propagate to the subcutaneous tunnel
surrounding the ePTFE graft and it becomes necessary
to remove it surgically.3 VAC therapy has been
reported to be useful in the treatment of wound
infections by decreasing the wound bacterial counts
and accelerating granulation tissue development.4,5
We demonstrated in four cases that graft salvage could
be obtained with aggressive local care, vacuum-
assisted therapy and systemic antibiotics. These
preliminary results suggest that a randomised clinical
trial comparing healing with or without vacuum-
assisted therapy should be carried out.
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